Direkt zum Inhalt
Merck

Plasticity of motor network and function in the absence of corticospinal projection.

Experimental neurology (2015-03-21)
Qi Han, Changshu Cao, Yuetong Ding, Kwok-Fai So, Wutian Wu, Yibo Qu, Libing Zhou
ZUSAMMENFASSUNG

Despite the obvious clinical interest, our understanding of how developmental mechanisms are redeployed during degeneration and regeneration after brain and spinal cord injuries remains quite rudimentary. In animal models of spinal cord injury, although spontaneous regeneration of descending axons is limited, compensation by intact corticospinal axons, descending tracts from the brainstem, and local intrinsic spinal networks all contribute to the recovery of motor function. Here, we investigated spontaneous motor compensation and plasticity that occur in the absence of corticospinal tract, using Celsr3|Emx1 mice in which the corticospinal tract is completely and specifically absent as a consequence of Celsr3 inactivation in the cortex. Mutant mice had no paresis, but displayed hyperactivity in open-field, and a reduction in skilled movements in food pellet manipulation tests. The number of spinal motoneurons was reduced and their terminal arbors at neuromuscular junctions were atrophic, which was reflected in electromyography deficits. Rubrospinal projections, calretinin-positive propriospinal projections, afferent innervation of motoneurons by calretinin-positive segmental interneurons, and terminal ramifications of monoaminergic projections were significantly increased. Contrary to control animals, mutants also developed a severe and persistent disability of forelimb use following the section of the rubrospinal tract at the C4 spinal level. These observations demonstrate for the first time that the congenital absence of the corticospinal tract induces spontaneous plasticity, both at the level of the motor spinal cord and in descending monoaminergic and rubrospinal projections. Such compensatory mechanisms could be recruited in case of brain or spinal cord lesion or degeneration.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Anti-Tyrosin-Hydroxylase-Antikörper, Chemicon®, from rabbit
Sigma-Aldrich
Anti-Cholin-Acetyltransferase-Antikörper, Chemicon®, from goat
Sigma-Aldrich
Monoklonaler Anti-GFAP-Antikörper (Glial Fibrillary Acidic Protein, Saures Gliafaserprotein) in Maus hergestellte Antikörper, clone G-A-5, ascites fluid
Sigma-Aldrich
Anti-GABA in Kaninchen hergestellte Antikörper, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anti-Neurofilament 200 in Kaninchen hergestellte Antikörper, IgG fraction of antiserum, buffered aqueous solution
Sigma-Aldrich
Monoklonaler Anti-Calbindin-D-28K-Antikörper in Maus hergestellte Antikörper, clone CB-955, ascites fluid
Sigma-Aldrich
Anti-Serotonin in Kaninchen hergestellte Antikörper, whole antiserum
Sigma-Aldrich
Anti-Parvalbumin-Antikörper, ascites fluid, clone PARV-19, Chemicon®